These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22477642)

  • 1. Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?
    Hermann S; Starsichova A; Waschkau B; Kuhlmann M; Wenning C; Schober O; Schäfers M
    J Nucl Cardiol; 2012 Jun; 19(3):609-17. PubMed ID: 22477642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques.
    Schäfers M; Schober O; Hermann S
    J Nucl Med; 2010 May; 51(5):663-6. PubMed ID: 20439506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [¹⁸F]-fluorodeoxyglucose PET imaging of atherosclerosis.
    Blomberg BA; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):1-7. PubMed ID: 25455876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of plaque vulnerability.
    Tavakoli S; Vashist A; Sadeghi MM
    J Nucl Cardiol; 2014 Dec; 21(6):1112-28; quiz 1129. PubMed ID: 25124827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis.
    Boswijk E; Bauwens M; Mottaghy FM; Wildberger JE; Bucerius J
    Methods; 2017 Nov; 130():90-104. PubMed ID: 28602809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular imaging with positron emission tomography.
    Joshi F; Rosenbaum D; Bordes S; Rudd JH
    J Intern Med; 2011 Aug; 270(2):99-109. PubMed ID: 21518037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
    Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
    Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions.
    Hartung D; Schäfers M; Fujimoto S; Levkau B; Narula N; Kopka K; Virmani R; Reutelingsperger C; Hofstra L; Kolodgie FD; Petrov A; Narula J
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S1-8. PubMed ID: 17497106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging of inflammation in atherosclerosis.
    Tarkin JM; Joshi FR; Rudd JH
    Nat Rev Cardiol; 2014 Aug; 11(8):443-57. PubMed ID: 24913061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of atherosclerosis with integrated PET imaging.
    Hammad B; Evans NR; Rudd JHF; Tawakol A
    J Nucl Cardiol; 2017 Jun; 24(3):938-943. PubMed ID: 28078575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond
    Bucerius J; Dijkgraaf I; Mottaghy FM; Schurgers LJ
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):251-265. PubMed ID: 30302506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
    MacAskill MG; Newby DE; Tavares AAS
    Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2010 Mar; 12(2):179-84. PubMed ID: 20425174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.
    Kang WJ
    Korean J Radiol; 2015; 16(6):1257-61. PubMed ID: 26576114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.